Related references
Note: Only part of the references are listed.Myocardial ischemia and ventricular fibrillation: Pathophysiology and clinical implications
Nazar Luqman et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands
Valdur Saks et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders - Network perspectives of cardiovascular metabolism
James N. Weiss et al.
JOURNAL OF LIPID RESEARCH (2006)
Effects of adenosine deaminase and A1 receptor deficiency in non-noxic and ischaemic mouse hearts
Laura Willems et al.
CARDIOVASCULAR RESEARCH (2006)
Inosine reduces ischemic brain injury in rats
H Shen et al.
STROKE (2005)
Astrocytes and neurons: different roles in regulating adenosine levels
FE Parkinson et al.
NEUROLOGICAL RESEARCH (2005)
Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance
ME Reichelt et al.
CIRCULATION RESEARCH (2005)
Animal models for the study of adenosine receptor function
R Yaar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Immunomodulatory and neuroprotective effects of inosine
G Haskó et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1
N Chaudary et al.
CARDIOVASCULAR RESEARCH (2004)
The equilibrative nucleoside transporter family, SLC29
SA Baldwin et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
The concentrative nucleoside transporter family, SLC28
JH Gray et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cε in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1
N Chaudary et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Inosine induces axonal rewiring and improves behavioral outcome after stroke
P Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Is there a place for preconditioning during cardiac operations in humans?
B Pouzet et al.
ANNALS OF THORACIC SURGERY (2002)
Transport characteristics of HL-1 cells: A new model for the study of adenosine physiology in cardiomyocytes
N Chaudary et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2002)
Signal transduction of ischemic preconditioning
R Schulz et al.
CARDIOVASCULAR RESEARCH (2001)
Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury
A Wakai et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Differential expression of human nucleoside transporters in normal and tumor tissue
M Pennycooke et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The role of adenosine in preconditioning
JW de Jong et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Ischemic preconditioning - From basic mechanisms to clinical applications
A Nakano et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells - ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine
JL Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells
SL Tilley et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport
S Kobayashi et al.
JOURNAL OF NEUROCHEMISTRY (2000)